These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 20174763

  • 1. Comparison of efficacy of antiplatelet treatments for patients with claudication. A meta-analysis.
    Basili S, Raparelli V, Vestri A, Di Tanna GL, Violi F.
    Thromb Haemost; 2010 Apr; 103(4):766-73. PubMed ID: 20174763
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
    BMJ; 1994 Jan 08; 308(6921):81-106. PubMed ID: 8298418
    [Abstract] [Full Text] [Related]

  • 5. The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials.
    WAVE Investigators.
    Am Heart J; 2006 Jan 08; 151(1):1-9. PubMed ID: 16368284
    [Abstract] [Full Text] [Related]

  • 6. Rationale for the use of antiplatelet drugs in patients with peripheral vascular disease.
    Violi F, Balsano F.
    Clin Trials Metaanal; 1994 Apr 08; 29(1):81-7. PubMed ID: 10150187
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH.
    Am J Manag Care; 2002 Dec 08; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis.
    Berger JS, Brown DL, Becker RC.
    Am J Med; 2008 Jan 08; 121(1):43-9. PubMed ID: 18187072
    [Abstract] [Full Text] [Related]

  • 11. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.
    Mehta SR, Yusuf S, Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study Investigators.
    Eur Heart J; 2000 Dec 08; 21(24):2033-41. PubMed ID: 11102254
    [Abstract] [Full Text] [Related]

  • 12. Aspirin in the secondary prevention of cardiovascular disease: an update of the APTC meta-analysis.
    Lièvre M, Cucherat M.
    Fundam Clin Pharmacol; 2010 Jun 08; 24(3):385-91. PubMed ID: 19678849
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.
    Dahabreh IJ, Economopoulos K.
    Clin Trials; 2008 Jun 08; 5(2):116-20. PubMed ID: 18375649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.